F.D.A. Approves First Gene-Altering Leukemia Treatment, Costing $475,000 by DENISE GRADY


The Food and Drug Administration approved the first treatment that genetically alters a patient’s own cells to fight cancer. It will cost $475,000.

Published: August 30, 2017 at 02:00AM

from NYT Health https://ift.tt/2xNqFWa